Abstract
The main objective of this study was to compare the behaviour of drug release among the famotidine polymorphs prepared by using various additives and solvents, by solvent evaporation method. The famotidine polyvinyl pyrrolidone polymorphs with different concentrations (0.5, 1 and 1.5%) were prepared by using solvent evaporation method. In these polymorphs of different concentrations 1% w/v polymorphs showed better release. Similarly, famotidine polymorphs of Tween 80 with different concentrations, polyethylene glycol 1% w/v and methanol was prepared. Famotidine polymorphs prepared the PVP (1% w/v) showed better drug release and solubility. DSC, FTIR, SEM and XRD studies were carried out. DSC studies revealed that PVP polymorphs were found to stable compared to other polymorphs. FTIR studies of the polymorphs prepared indicated that there was an interaction found in all polymorphs except PVP polymorphs indicating the absence of drug-additive interaction. SEM studies of PVP and methanol polymorphs revealed that they are tabular and prismatic and columnar respectively. These changes in morphology were due to variations in face dimensions and also properties of additives and solvent used in the preparation. XRD studies revealed that there is an increase in crystallinity in methanol polymorphs when compared to PVP polymorphs and pure drug. The mechanism of drug release was determined using zero order, first order and Hixon-Crowel equations. From the drug release kinetics these polymorphs followed first order and Hixon-Crowel release kinetics, exhibited fair linearity in their dissolution data. Further, in vivo studies were carried out for the evaluation of antiulcer activity. Based upon the drug release pattern and its kinetics only two of the prepared polymorphs of famotidine i.e. famotidine PVP polymorphs and famotidine methanol polymorphs were selected for animal studies. Antiulcer studies were carried out using pylorus ligation model and estimation of antioxidant parameters was also done. In these studies also polymorphs of PVP showed better antiulcer activity and also significant antioxidant activity when compared to famotidine (pure) and famotidine methanol polymorphs. Hence in the present investigation, amongst the various polymorphs of famotidine prepared, PVP polymorphs were found to possess good dissolution behaviour, stability and absence of drug additive interactions. Further, in vivo studies confirmed the better therapeutic action of these PVP polymorphs over the pure drug and famotidine methanol polymorphs.
Keywords: Famotidine, polymorphs, antiulcer activity, antioxidant activity, Tween 80, DSC, FTIR, SEM, XRD, Polymorphism, PVP, Anti Ulcer, lipid peroxidation, catalase, glutathione, IR analysis, Visible spectrophotometer, Elico, SMP, calorimeter
Current Drug Discovery Technologies
Title: Preparation and Evaluation of Famotidine Polymorphs
Volume: 7 Issue: 2
Author(s): Ravouru Nagaraju, Ande Penchala Prathusha, Penjury Subhash Chandra Bose, Rajesh Kaza3 and Koganti Bharathi
Affiliation:
Keywords: Famotidine, polymorphs, antiulcer activity, antioxidant activity, Tween 80, DSC, FTIR, SEM, XRD, Polymorphism, PVP, Anti Ulcer, lipid peroxidation, catalase, glutathione, IR analysis, Visible spectrophotometer, Elico, SMP, calorimeter
Abstract: The main objective of this study was to compare the behaviour of drug release among the famotidine polymorphs prepared by using various additives and solvents, by solvent evaporation method. The famotidine polyvinyl pyrrolidone polymorphs with different concentrations (0.5, 1 and 1.5%) were prepared by using solvent evaporation method. In these polymorphs of different concentrations 1% w/v polymorphs showed better release. Similarly, famotidine polymorphs of Tween 80 with different concentrations, polyethylene glycol 1% w/v and methanol was prepared. Famotidine polymorphs prepared the PVP (1% w/v) showed better drug release and solubility. DSC, FTIR, SEM and XRD studies were carried out. DSC studies revealed that PVP polymorphs were found to stable compared to other polymorphs. FTIR studies of the polymorphs prepared indicated that there was an interaction found in all polymorphs except PVP polymorphs indicating the absence of drug-additive interaction. SEM studies of PVP and methanol polymorphs revealed that they are tabular and prismatic and columnar respectively. These changes in morphology were due to variations in face dimensions and also properties of additives and solvent used in the preparation. XRD studies revealed that there is an increase in crystallinity in methanol polymorphs when compared to PVP polymorphs and pure drug. The mechanism of drug release was determined using zero order, first order and Hixon-Crowel equations. From the drug release kinetics these polymorphs followed first order and Hixon-Crowel release kinetics, exhibited fair linearity in their dissolution data. Further, in vivo studies were carried out for the evaluation of antiulcer activity. Based upon the drug release pattern and its kinetics only two of the prepared polymorphs of famotidine i.e. famotidine PVP polymorphs and famotidine methanol polymorphs were selected for animal studies. Antiulcer studies were carried out using pylorus ligation model and estimation of antioxidant parameters was also done. In these studies also polymorphs of PVP showed better antiulcer activity and also significant antioxidant activity when compared to famotidine (pure) and famotidine methanol polymorphs. Hence in the present investigation, amongst the various polymorphs of famotidine prepared, PVP polymorphs were found to possess good dissolution behaviour, stability and absence of drug additive interactions. Further, in vivo studies confirmed the better therapeutic action of these PVP polymorphs over the pure drug and famotidine methanol polymorphs.
Export Options
About this article
Cite this article as:
Nagaraju Ravouru, Penchala Prathusha Ande, Subhash Chandra Bose Penjury, Kaza3 Rajesh and Bharathi Koganti, Preparation and Evaluation of Famotidine Polymorphs, Current Drug Discovery Technologies 2010; 7 (2) . https://dx.doi.org/10.2174/157016310793180639
DOI https://dx.doi.org/10.2174/157016310793180639 |
Print ISSN 1570-1638 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6220 |
Related Books

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Receptor-Binding and Pharmacokinetic Properties of Dopaminergic Agonists
Current Topics in Medicinal Chemistry Myocardial Quantitative Analysis in Physiological and Pathological Ventricular Hypertrophy: The Increasing Role of Doppler Myocardial Imaging
Current Cardiology Reviews LPS In Patients With Left Ventricular Dysfunction Of Ischemic And Non-Ischemic Origin
Cardiovascular & Hematological Disorders-Drug Targets Recent Advances in the Management of Pulmonary Arterial Hypertension
Current Respiratory Medicine Reviews Mineralocorticoid Receptor Blockade in the Protection of Target Organ Damage
Cardiovascular & Hematological Agents in Medicinal Chemistry The Fetal Cardiac Function
Current Cardiology Reviews Applications of Molecular Imaging in Cancer Gene Therapy
Current Gene Therapy Combination of Photodynamic Therapy with Anti-Cancer Agents
Current Medicinal Chemistry Antihypertensive Drugs Metabolism: An Update to Pharmacokinetic Profiles and Computational Approaches
Current Pharmaceutical Design Gender Differences in Autonomic Control of the Cardiovascular System
Current Pharmaceutical Design An Introduction to Hardware and Methods for Biopotential Measurements: A Review
Recent Patents on Biomedical Engineering (Discontinued) The Role of Selectins During Lung Inflammation and Their Potential Impact for Innovative Therapeutic Strategies
Current Respiratory Medicine Reviews Antidepressants, β-Arrestins and GRKs: From Regulation of Signal Desensitization to Intracellular Multifunctional Adaptor Functions
Current Pharmaceutical Design Extrahepatic Metabolism may Complicate the IVIVC in Rats
Drug Metabolism Letters The Role of Apelins in the Physiology of the Heart
Protein & Peptide Letters Novel Next-Generation Sequencing and Networks-Based Therapeutic Targets: Realistic and More Effective Drug Design and Discovery
Current Pharmaceutical Design Pulmonary Vascular Function in Insulin Resistance and Diabetes
Current Vascular Pharmacology Poly(ADP-Ribose)Polymerase 1 (PARP-1) Activation and Ca<sup>2+</sup> Permeable α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid (AMPA) Channels in Post-Ischemic Brain Damage: New Therapeutic Opportunities?
CNS & Neurological Disorders - Drug Targets Hypertension in the Elderly: An Evidence-based Review
Current Pharmaceutical Design Recent Patents on Wireless Capsule Endoscopy
Recent Patents on Biomedical Engineering (Discontinued)